Key statistics
As of last trade Penumbra Inc (0P8:FRA) traded at 233.20, -8.19% below its 52-week high of 254.00, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 228.00 |
---|---|
High | 233.20 |
Low | 227.70 |
Bid | 234.00 |
Offer | 236.60 |
Previous close | 228.20 |
Average volume | 26.44 |
---|---|
Shares outstanding | 38.38m |
Free float | 36.89m |
P/E (TTM) | 279.56 |
Market cap | 9.23bn USD |
EPS (TTM) | 0.8602 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:55 GMT.
More ▼
Press releases
- Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
- New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
- Penumbra, Inc. Reports Third Quarter 2024 Financial Results
- Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
- Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous Thromboembolism
- Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
- Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
- Penumbra, Inc. to Present at the Baird Global Healthcare Conference
More ▼